Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126288311 | 12628831 | 1 | I | 20160804 | 20160808 | 20160808 | EXP | US-009507513-1608USA003235 | MERCK | 0.00 | M | Y | 0.00000 | 20160808 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126288311 | 12628831 | 1 | SS | LEVOTHYROXINE SODIUM. | LEVOTHYROXINE SODIUM | 1 | Oral | 100 MICROGRAM, QD | 0 | 100 | UG | TABLET | QD | ||||||
| 126288311 | 12628831 | 2 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, QD | 19766 | 40 | MG | FILM-COATED TABLET | QD | ||||||
| 126288311 | 12628831 | 3 | SS | SIMVASTATIN. | SIMVASTATIN | 1 | 19766 | FILM-COATED TABLET | |||||||||||
| 126288311 | 12628831 | 4 | SS | AMITRIPTYLINE HYDROCHLORIDE. | AMITRIPTYLINE HYDROCHLORIDE | 1 | Oral | 100 MG, AT BEDTIME | 0 | 100 | MG | TABLET | QD | ||||||
| 126288311 | 12628831 | 5 | SS | AMITRIPTYLINE HYDROCHLORIDE. | AMITRIPTYLINE HYDROCHLORIDE | 1 | 0 | TABLET | |||||||||||
| 126288311 | 12628831 | 6 | SS | NEURONTIN | GABAPENTIN | 1 | 300 MG, QID | 0 | 300 | MG | QID | ||||||||
| 126288311 | 12628831 | 7 | SS | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | 1 MG, QD | 0 | 1 | MG | QD | ||||||||
| 126288311 | 12628831 | 8 | SS | LORAZEPAM. | LORAZEPAM | 1 | 0.5 MG, QID | 0 | .5 | MG | QID | ||||||||
| 126288311 | 12628831 | 9 | SS | LORAZEPAM. | LORAZEPAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126288311 | 12628831 | 1 | Thyroid disorder |
| 126288311 | 12628831 | 2 | Chronic kidney disease |
| 126288311 | 12628831 | 3 | Nephrectomy |
| 126288311 | 12628831 | 4 | Depression |
| 126288311 | 12628831 | 5 | Insomnia |
| 126288311 | 12628831 | 6 | Neuralgia |
| 126288311 | 12628831 | 7 | Diabetes mellitus |
| 126288311 | 12628831 | 8 | Dizziness |
| 126288311 | 12628831 | 9 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126288311 | 12628831 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126288311 | 12628831 | Arthralgia | |
| 126288311 | 12628831 | Malaise | |
| 126288311 | 12628831 | Migraine | |
| 126288311 | 12628831 | Pain in extremity | |
| 126288311 | 12628831 | Renal failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126288311 | 12628831 | 1 | 2008 | 0 | ||
| 126288311 | 12628831 | 2 | 2011 | 0 | ||
| 126288311 | 12628831 | 4 | 1986 | 0 | ||
| 126288311 | 12628831 | 6 | 2007 | 0 | ||
| 126288311 | 12628831 | 7 | 2013 | 0 | ||
| 126288311 | 12628831 | 8 | 1986 | 0 |